Partnership Established to Improve Medical Software Interfacing
|
By LabMedica International staff writers Posted on 25 Feb 2014 |
A leading portal for medical practices and hospitals has an agreement with a medical software company to offer enhanced interoperability with electronic medical record (EMR) and other medical software vendors.
Healthcare portal software Bridge Patient Portal (San Diego, CA, USA) is partnering with the X-Link Solutions Network (Land O' Lakes, FL, USA) to improve Bridge’s access to the X-Link-compatible EMR/electronic health record (EMR/EHR) systems databases and to help the portal to optimally interface with them.
The X-Link range of products allows for streamlined data sharing between a wide range of medical software packages, including EMR systems, practice management systems, appointment reminder software, laboratory, and picture archiving and communication system (PACS) imaging systems, prescription systems, and health information exchanges (HIEs).
X-Link offers real-time interfacing between these systems and provides the required data translations to allow for any type of data, format, and data transport method to work seamlessly between systems. The users of EMRs and patient portals licensed by different companies can interface the two systems and achieve Meaningful Use (MU) and Health Insurance Portability and Accountability (HIPAA) compliance.
With the advent of cloud platforms, an upsurge of data and new ways for information both in the online and mobile worlds, the role of systems integration is becoming increasingly critical. X-Link provides the integration requirements to tap into these multiplatform and multiapplication software solutions while remaining advocates for utilizing existing medical technology solutions.
Although Bridge Patient Portal is HL [Health Level]7-compliant on its own and interfaces with any EMR, the partnership with X-Link gives Bridge immediate access to direct database interfaces, improving mapping, making the interfacing and implementation process more rapid for the user, and avoiding many of the difficulties that can occur from custom interfaces.
“Interoperability is what will define healthcare IT [information technology] in the years to come,” stated John Deutsch, founder and CEO of Bridge’s parent company Medical Web Experts. “Our partnership with X-Link is demonstrative of our goal to support interfaces with all the major EMR and practice management systems in the market.”
Bridge Patient Portal is certified by the Office of National Coordinator for Health Information Technology (ONC) for 2014, signifying its HIPAA compliance and support for portable medical record document technologies such as the Continuity of Care Document (CCD). When used with a certified EMR, Bridge can help healthcare professionals meet 100% of MU stage 1 and 2 criteria.
Bridge is also well suited for practices and hospitals of any size, is completely customizable, and has a full range of features. This includes appointment requests, e-consultations, prescription refills, online bill pay, medical records collaboration, and others that help improve patient engagement. As a web-based cloud application that is very user-friendly and easy to implement, many practices are choosing to step outside of their EMR provider for a portal to help them qualify for US federal incentives under MU.
Through their new partnership with X-Link, Bridge can now interface quickly and efficiently with over 170 electronic medical record systems and 136 practice management systems.
Bridge Patient Portal is a novel system for patient engagement and practice management. With a full range of customizable features, it is a suitable solution for practices, hospitals, and healthcare organizations interested in simplifying their office functions while building patient-provider relationships. The portal operates in many different settings, including being offered as a software-as-a-service (SaaS) model and a client-hosted client/server model. The portal can also be customized to each practice’s requirements, both in terms of design and user interface layout.
Easy Business Software’s X-Link Medical Software Interfacing products integrate different medical software programs. X-Link develops many interfaces via direct database access, thereby bypassing many costs and complexities imposed by EMR vendors for interface costs, support, and maintenance. The X-Link Medical Software Interfacing product prevents double entry of patient data, charge information, and clinical data across any type of healthcare system.
Related Links:
Bridge Patient Portal
X-Link Solutions Network
Healthcare portal software Bridge Patient Portal (San Diego, CA, USA) is partnering with the X-Link Solutions Network (Land O' Lakes, FL, USA) to improve Bridge’s access to the X-Link-compatible EMR/electronic health record (EMR/EHR) systems databases and to help the portal to optimally interface with them.
The X-Link range of products allows for streamlined data sharing between a wide range of medical software packages, including EMR systems, practice management systems, appointment reminder software, laboratory, and picture archiving and communication system (PACS) imaging systems, prescription systems, and health information exchanges (HIEs).
X-Link offers real-time interfacing between these systems and provides the required data translations to allow for any type of data, format, and data transport method to work seamlessly between systems. The users of EMRs and patient portals licensed by different companies can interface the two systems and achieve Meaningful Use (MU) and Health Insurance Portability and Accountability (HIPAA) compliance.
With the advent of cloud platforms, an upsurge of data and new ways for information both in the online and mobile worlds, the role of systems integration is becoming increasingly critical. X-Link provides the integration requirements to tap into these multiplatform and multiapplication software solutions while remaining advocates for utilizing existing medical technology solutions.
Although Bridge Patient Portal is HL [Health Level]7-compliant on its own and interfaces with any EMR, the partnership with X-Link gives Bridge immediate access to direct database interfaces, improving mapping, making the interfacing and implementation process more rapid for the user, and avoiding many of the difficulties that can occur from custom interfaces.
“Interoperability is what will define healthcare IT [information technology] in the years to come,” stated John Deutsch, founder and CEO of Bridge’s parent company Medical Web Experts. “Our partnership with X-Link is demonstrative of our goal to support interfaces with all the major EMR and practice management systems in the market.”
Bridge Patient Portal is certified by the Office of National Coordinator for Health Information Technology (ONC) for 2014, signifying its HIPAA compliance and support for portable medical record document technologies such as the Continuity of Care Document (CCD). When used with a certified EMR, Bridge can help healthcare professionals meet 100% of MU stage 1 and 2 criteria.
Bridge is also well suited for practices and hospitals of any size, is completely customizable, and has a full range of features. This includes appointment requests, e-consultations, prescription refills, online bill pay, medical records collaboration, and others that help improve patient engagement. As a web-based cloud application that is very user-friendly and easy to implement, many practices are choosing to step outside of their EMR provider for a portal to help them qualify for US federal incentives under MU.
Through their new partnership with X-Link, Bridge can now interface quickly and efficiently with over 170 electronic medical record systems and 136 practice management systems.
Bridge Patient Portal is a novel system for patient engagement and practice management. With a full range of customizable features, it is a suitable solution for practices, hospitals, and healthcare organizations interested in simplifying their office functions while building patient-provider relationships. The portal operates in many different settings, including being offered as a software-as-a-service (SaaS) model and a client-hosted client/server model. The portal can also be customized to each practice’s requirements, both in terms of design and user interface layout.
Easy Business Software’s X-Link Medical Software Interfacing products integrate different medical software programs. X-Link develops many interfaces via direct database access, thereby bypassing many costs and complexities imposed by EMR vendors for interface costs, support, and maintenance. The X-Link Medical Software Interfacing product prevents double entry of patient data, charge information, and clinical data across any type of healthcare system.
Related Links:
Bridge Patient Portal
X-Link Solutions Network
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







